Karen L Hall

Karen L Hall, MD

Professor Emeritus

Department: MD-FAMILY MED CENTER AT MAIN
Business Email: hall@ufl.edu

About Karen L Hall

Dr. Hall retired a full Professor of the Family Medicine Residency Program at the University of Florida (UF) College of Medicine. Prior to her start at the University of Florida, she served in the United States Army Medical Corps and also served as an emergency department physician. Dr. Hall completed her family medicine residency at UF, and in 1990 became Board Certified in Family Medicine and joined the staff at Community Health and Family Medicine. In 1992 she moved to Charleston, South Carolina where she had dual appointments in Family Medicine and Psychiatry.

In 1996 Dr. Hall returned to UF as Program Director of the Community Health and Family Medicine Family Medicine Residency Program  where she remained in the postion for over 20 years. Dr. Hall has an interest in curriculum development for residents who are training in Family Medicine, quality improvement and general primary care.

Accomplishments

Exemplary Teacher Award
2013-2015 · University of Florida College of Medicine
Superior Accomplishment Award, Division V
2011 · University of Florida
Exemplary Teacher Award
2007-2009 · University of Florida College of Medicine
Best Doctors in America
2002-2016 · Best Doctors in America

Publications

2018
Neuroleptic Malignant Syndrome: Diagnosis and Management.
The primary care companion for CNS disorders. 20(1) [DOI] 10.4088/PCC.17r02185. [PMID] 29325237.
2016
Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
Hypertension (Dallas, Tex. : 1979). 67(3):556-63 [DOI] 10.1161/HYPERTENSIONAHA.115.06345. [PMID] 26729753.
2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
Journal of hypertension. 33(11):2278-85 [DOI] 10.1097/HJH.0000000000000714. [PMID] 26425837.
2014
Alteration in fasting glucose after prolonged treatment with a thiazide diuretic.
Diabetes research and clinical practice. 104(3):363-9 [DOI] 10.1016/j.diabres.2014.04.004. [PMID] 24794890.
2014
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
Pharmacotherapy. 34(11):1132-40 [DOI] 10.1002/phar.1483. [PMID] 25202885.
2012
Antihypertensive Medication Exposure and Adverse Glycemic Effects: An Evaluation of Fasting and Stimulated Glucose
Clinical Pharmacology & Therapeutics. 91
2010
Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.
Pharmacotherapy. 30(9):872-8 [DOI] 10.1592/phco.30.9.872. [PMID] 20795842.
2010
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
Hypertension (Dallas, Tex. : 1979). 55(1):61-8 [DOI] 10.1161/HYPERTENSIONAHA.109.139592. [PMID] 19917874.
2009
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study
Pharmacotherapy. [DOI] 10.1592/phco.29.10.1157. [PMID] 19792989.
2009
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Pharmacotherapy. 29(10):1157-65 [DOI] 10.1592/phco.29.10.1157. [PMID] 19792989.
2005
Evaluation and management of apparent life-threatening events in children.
American family physician. 71(12):2301-8 [PMID] 15999867.
View on: PubMed
2001
Neuroleptic malignant syndrome due to olanzapine.
Psychopharmacology bulletin. 35(3):49-54 [PMID] 12397878.
View on: PubMed
1992
Metastasis of unknown origin.
Primary care. 19(4):747-57 [PMID] 1465485.
View on: PubMed
1992
Panic disorder. Recognizing and managing the ‘real thing’.
Postgraduate medicine. 91(7):99-102, 105 [PMID] 1589372.
View on: PubMed
1992
Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Primary care. 19(3):607-20 [PMID] 1410066.
View on: PubMed

Grants

Aug 2015 – May 2016
Dose-Finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects with Type 2 Diabetes Subtitle: A 26-Week, Multicentre, Double-Blind, Randomised, Controlled Dose-Finding Trial, Phase 2
Role: Principal Investigator
Funding: NOVO NORDISK
Nov 2013 – Nov 2016
A Randomized Multicountry, Multicenter Double-blind Parallel placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy
Role: Principal Investigator
Funding: ABBVIE
Sep 2010 – Jun 2018
Expanding an Established Family Medicine Residency by adding a Rural Track Program
Role: Principal Investigator
Funding: US HLTH RESOURCES AND SERV ADMN

Teaching Profile

Courses Taught
2018
MDC7123 Sr Com Hlth Fam Clerk
2018
MDC7124 Family Med/Geriatrics
2013-2018
MDT7100 Elect Top/Community
2009-2013
BCC7174 Sr Com Hlth Fam Clerk
2010-2013
MEL7947 Elect Top/Community
2009
BCC7170 Family Med/Geriatrics

Contact Details

Emails:
Business:
hall@ufl.edu